Class Information

Class Information

Three Day STI Overview
Virtual Classroom, MD
Credit Hours:

This 3 Day STI Overview course is open to health educators, counselor outreach workers and others to describe STIs in the community and through faculty modeling, demonstrates the methods for delivering this information to clients being served.

This 3 Day STI Overivew training program will educate the providers regarding the sign, symptoms and how the various STIs are transmitted.  This will educate the providers to pass the correct information onto their clientele.  This will inform the providers about the scope of the problem and the resources available to address it.  December 13-15, 2021


At the conclusion of the session, the participant will be able to accomplish the following:

1.         Describe most recent epidemiology for reportable STIs in the United States and locally

2.         Identify the common bacterial or antibiotic treated STIs, including but not limited

            to GC, CT, Syphilis, and Trichomoniasis.

3.         Identify the common viral STIs including viral hepatitis, Herpes Simplex Virus, Human

Papillomavirus and Human Immunodeficiency Virus

4.         Describe at least 2 population factors increasing one's risk for acquisition of STI

5.         Discuss provider skills in sexual health service such as taking a sexual history and

            understanding partner services

6.         Demonstrate effective team skills by effectively sharing information about STIs, listening and

            responding to feedback from others, and using simple communication. 


Origination Date: 5/11/2020

Expiration Date: 5/11/2022





 CDC accreditation logo 0820

In support of improving patient care, this activity has been planned and implemented by Centers for Disease Control and Prevention and STD/HIV Prevention Training Center at Johns Hopkins.   The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


CME:  The Centers for Disease Control and Prevention designates this live activity for a maximum of 16.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 CNE:  The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation.

This activity provides 16.7 contact hours.

CEU:  The Centers for Disease Control and Prevention is authorized by IACET to 1.7 CEU's for this program.

CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 17.0 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 17.0. Continuing Competency credits available are 17.0 CDC provider number 98614.

For Certified Public Health Professionals (CPH)

The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 17.0 CPH recertification credits for this program.

DISCLOSURE:  In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use.

CDC, our planners, presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial.

Content will not include any discussion of the unlabeled use of a product or a product under investigational use with the exception of Dr. Matthew Hamill’s discussion of Gonorrhea and Chlamydia. He will be discussing how some assays may not yet be FDA cleared and are in the testing developmental phase. Also extra genital screening for gonorrhea and chlamydia.

The Centers for Disease Control and Prevention and STD/HIV Prevention Training Center at Johns Hopkins are jointly providing the CNE for this activity.

CDC did not accept commercial support for this continuing education activity.


Jeanne Hoover 410-206-1156